DOJ-OGR-00014962.jpg
585 KB
Extraction Summary
2
People
2
Organizations
1
Locations
2
Events
1
Relationships
3
Quotes
Document Information
Type:
Court transcript
File Size:
585 KB
Summary
This is page 86 of a court transcript (Case 1:20-cr-00330-PAE) filed on January 15, 2025. It features the direct examination of a witness named Rocchio (likely a clinical expert), who is testifying about the importance of asking patients about their disclosure history regarding child sexual abuse. The witness explains that delayed disclosure often correlates with a lack of immediate medical care and that the response a victim receives upon disclosure significantly impacts outcomes.
People (2)
| Name | Role | Context |
|---|---|---|
| Rocchio | Witness / Clinical Practitioner |
Providing direct testimony regarding clinical practices, assessment of sexual abuse survivors, and disclosure dynamic...
|
| Unidentified Attorney | Interrogator |
The person asking questions marked by 'Q.'
|
Organizations (2)
| Name | Type | Context |
|---|---|---|
| Southern District Reporters, P.C. |
Transcription service provider listed in the footer.
|
|
| DOJ |
Department of Justice, referenced in the Bates stamp 'DOJ-OGR-00014962'.
|
Locations (1)
| Location | Context |
|---|---|
|
Implied jurisdiction based on the court reporter's name (likely SDNY).
|
Relationships (1)
Witness discusses their 'clinical practice' and asking questions to people about child sexual abuse.
Key Quotes (3)
"In your clinical practice, have you treated and evaluated patients who did not disclose sexual abuse they experienced as children but disclosed such abuse later? A. Yes."Source
DOJ-OGR-00014962.jpg
Quote #1
"we know that if people don't tell, then that also means they likely didn't get medical care or assistance at the time of the event."Source
DOJ-OGR-00014962.jpg
Quote #2
"when someone is talking about their experiences, to inquire of them what their experiences were like with disclosure, because that can be so impactful."Source
DOJ-OGR-00014962.jpg
Quote #3
Full Extracted Text
Complete text extracted from the document (1,714 characters)
Case 1:20-cr-00330-PAE Document 782 Filed 01/15/25 Page 86 of 158 86
LBAAMAX3ps Rocchio - Direct
LBAAMAX3ps Rocchio - Direct
1 the first time they've ever talked about it.
2 Similarly, through trainings and readings and in my
3 graduate program, also being taught that when you make an
4 assessment it's really important, when someone is talking about
5 their experiences, to inquire of them what their experiences
6 were like with disclosure, because that can be so impactful.
7 Q. In your clinical practice, have you treated and evaluated
8 patients who did not disclose sexual abuse they experienced as
9 children but disclosed such abuse later?
10 A. Yes.
11 Q. Can you explain.
12 A. I've, as I mentioned, when I do an assessment and I'm
13 talking with people about experiences of child sexual abuse,
14 one of the common and important questions I will ask is: and at
15 the time that this was happening or at some point later, did
16 you share your experiences with anyone; did you tell anyone.
17 And as I said, in terms of a -- in a clinical setting, that
18 information is very important. We know that the responses of
19 the person that they told have significant impact on the
20 adverse, potentially adverse outcomes.
21 Also, of course we know that if people don't tell,
22 then that also means they likely didn't get medical care or
23 assistance at the time of the event. And that also is highly
24 relevant.
25 So I see that a lot in my clinical practice. And
2 Similarly, through trainings and readings and in my
3 graduate program, also being taught that when you make an
4 assessment it's really important, when someone is talking about
5 their experiences, to inquire of them what their experiences
6 were like with disclosure, because that can be so impactful.
7 Q. In your clinical practice, have you treated and evaluated
8 patients who did not disclose sexual abuse they experienced as
9 children but disclosed such abuse later?
10 A. Yes.
11 Q. Can you explain.
12 A. I've, as I mentioned, when I do an assessment and I'm
13 talking with people about experiences of child sexual abuse,
14 one of the common and important questions I will ask is: and at
15 the time that this was happening or at some point later, did
16 you share your experiences with anyone; did you tell anyone.
17 And as I said, in terms of a -- in a clinical setting, that
18 information is very important. We know that the responses of
19 the person that they told have significant impact on the
20 adverse, potentially adverse outcomes.
21 Also, of course we know that if people don't tell,
22 then that also means they likely didn't get medical care or
23 assistance at the time of the event. And that also is highly
24 relevant.
25 So I see that a lot in my clinical practice. And
SOUTHERN DISTRICT REPORTERS, P.C.
(212) 805-0300
(212) 805-0300
DOJ-OGR-00014962
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document